|
OMIM |
Link |
Information gain |
01 |
|
SLE
|
[NCBI]
|
0.00118309
|
|
|
PCD
|
[NCBI]
|
0.000948967
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
0.000809831
|
|
|
microphthalmia with limb anomalies
|
[NCBI]
|
0.000587372
|
|
|
ehlers-danlos syndrome, type vib
|
[NCBI]
|
0.000512699
|
|
|
anencephaly
|
[NCBI]
|
0.000442837
|
|
|
FRNS
|
[NCBI]
|
0.000354149
|
|
|
EEC1
|
[NCBI]
|
0.000330563
|
|
|
PEE1
|
[NCBI]
|
0.000314141
|
|
|
DWS
|
[NCBI]
|
0.000306591
|
|
|
PCOS1
|
[NCBI]
|
0.000306591
|
|
|
AFP
|
[NCBI]
|
0.000302945
|
|
|
CPI
|
[NCBI]
|
0.000155026
|
|
|
SRS
|
[NCBI]
|
0.000147464
|
|
|
blood group, p system
|
[NCBI]
|
0.000134804
|
|
|
RA
|
[NCBI]
|
0.00013037
|
|
|
antiphospholipid syndrome
|
[NCBI]
|
0.00012451
|
|
|
PAEP
|
[NCBI]
|
0.000117606
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
0.000112455
|
|
|
A4GALT
|
[NCBI]
|
0.000110723
|
|
|
blood group--en
|
[NCBI]
|
0.000105899
|
|
|
radioulnar synostosis, radial ray abnormalities, and severe malformations in the male
|
[NCBI]
|
0.000105899
|
|
|
CF
|
[NCBI]
|
0.000102863
|
|
|
C5R1
|
[NCBI]
|
9.68115e-05
|
|
|
phenylketonuria
|
[NCBI]
|
9.05683e-05
|
|
|
uterine anomalies
|
[NCBI]
|
7.49908e-05
|
|
|
IGKV1OR2108
|
[NCBI]
|
7.20285e-05
|
|
|
FUT1
|
[NCBI]
|
7.20285e-05
|
|
|
FLNA
|
[NCBI]
|
6.70546e-05
|
|
|
cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency
|
[NCBI]
|
6.54335e-05
|
|
|
isotretinoin embryopathy-like syndrome
|
[NCBI]
|
6.21929e-05
|
|
|
STHAG1
|
[NCBI]
|
6.21929e-05
|
|
|
B3GALNT1
|
[NCBI]
|
5.82548e-05
|
|
|
chondrodysplasia punctata, tibia-metacarpal type
|
[NCBI]
|
5.72018e-05
|
|
|
globozoospermia
|
[NCBI]
|
5.51937e-05
|
|
|
PCS
|
[NCBI]
|
5.34123e-05
|
|
|
LISX1
|
[NCBI]
|
5.34123e-05
|
|
|
SPHK2
|
[NCBI]
|
5.30604e-05
|
|
|
MCOPS9
|
[NCBI]
|
5.18121e-05
|
|
|
LNPEP
|
[NCBI]
|
4.96897e-05
|
|
|
SPHK1
|
[NCBI]
|
4.7185e-05
|
|
|
IP
|
[NCBI]
|
4.58525e-05
|
|
|
nondisjunction
|
[NCBI]
|
4.56129e-05
|
|
|
GDF15
|
[NCBI]
|
4.51904e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
4.46226e-05
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
4.46226e-05
|
|
|
SFTPD
|
[NCBI]
|
4.35329e-05
|
|
|
CDPX1
|
[NCBI]
|
4.28144e-05
|
|
|
MCPH1
|
[NCBI]
|
4.28144e-05
|
|
|
RHS
|
[NCBI]
|
4.1197e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
4.04371e-05
|
|
|
PRL
|
[NCBI]
|
4.02944e-05
|
|
|
PRG4
|
[NCBI]
|
3.97765e-05
|
|
|
THBD
|
[NCBI]
|
3.97765e-05
|
|
|
HLA-G
|
[NCBI]
|
3.97765e-05
|
|
|
NEU1
|
[NCBI]
|
3.70676e-05
|
|
|
fraser syndrome
|
[NCBI]
|
3.44914e-05
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
3.22206e-05
|
|
|
DHCR7
|
[NCBI]
|
3.22048e-05
|
|
|
SOCS1
|
[NCBI]
|
3.12934e-05
|
|
|
FGG
|
[NCBI]
|
3.12934e-05
|
|
|
PMM2
|
[NCBI]
|
3.04608e-05
|
|
|
ICAM1
|
[NCBI]
|
2.96948e-05
|
|
|
TFPI2
|
[NCBI]
|
2.83254e-05
|
|
|
PROCR
|
[NCBI]
|
2.68515e-05
|
|
|
neuraminidase deficiency
|
[NCBI]
|
2.67042e-05
|
|
|
RS1
|
[NCBI]
|
2.60662e-05
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
2.48398e-05
|
|
|
DMPK
|
[NCBI]
|
2.42458e-05
|
|
|
FMF
|
[NCBI]
|
2.41385e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
2.34537e-05
|
|
|
TCOF
|
[NCBI]
|
2.32015e-05
|
|
|
NPS
|
[NCBI]
|
2.27682e-05
|
|
|
ALGS1
|
[NCBI]
|
2.25568e-05
|
|
|
SLC4A1
|
[NCBI]
|
2.20483e-05
|
|
|
UCN
|
[NCBI]
|
2.18869e-05
|
|
|
HGPS
|
[NCBI]
|
2.13556e-05
|
|
|
BLM
|
[NCBI]
|
2.13556e-05
|
|
|
IL10
|
[NCBI]
|
2.11201e-05
|
|
|
MTHFR
|
[NCBI]
|
2.08307e-05
|
|
|
G6PD
|
[NCBI]
|
2.02811e-05
|
|
|
AVSD
|
[NCBI]
|
1.97418e-05
|
|
|
factor v deficiency
|
[NCBI]
|
1.95087e-05
|
|
|
VIM
|
[NCBI]
|
1.92662e-05
|
|
|
NS1
|
[NCBI]
|
1.7728e-05
|
|
|
JAK2
|
[NCBI]
|
1.74376e-05
|
|
|
CDLS1
|
[NCBI]
|
1.52892e-05
|
|
|
AMH
|
[NCBI]
|
1.36052e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.03134e-05
|
|
|
FGF7
|
[NCBI]
|
9.88949e-06
|
|
|
DGS
|
[NCBI]
|
9.63295e-06
|
|
|
EGF
|
[NCBI]
|
9.58171e-06
|
|
|
PCNA
|
[NCBI]
|
9.06649e-06
|
|
|
TNFSF6
|
[NCBI]
|
8.97977e-06
|
|
|
MODY
|
[NCBI]
|
7.65077e-06
|
|
|
TPO
|
[NCBI]
|
7.62252e-06
|
|
|
SLOS
|
[NCBI]
|
7.39681e-06
|
|
|
PXE
|
[NCBI]
|
6.96046e-06
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
6.72896e-06
|
|
|
CD
|
[NCBI]
|
6.64375e-06
|
|
|
GNRH1
|
[NCBI]
|
6.55391e-06
|
|
|
TLR4
|
[NCBI]
|
6.20932e-06
|
|
|
CAT
|
[NCBI]
|
6.02112e-06
|
|
|
MFS
|
[NCBI]
|
5.99526e-06
|
|
|
TNF
|
[NCBI]
|
4.16939e-06
|
|
|
PPARA
|
[NCBI]
|
3.15602e-06
|
|
|
HGF
|
[NCBI]
|
3.02872e-06
|
|
|
CEACAM5
|
[NCBI]
|
1.62551e-06
|
|
|
ADA
|
[NCBI]
|
1.2359e-06
|
|
|
GFAP
|
[NCBI]
|
1.14939e-06
|
|
|
F3
|
[NCBI]
|
4.52858e-07
|
|
|
TG
|
[NCBI]
|
3.76965e-07
|
|
|
VEGF
|
[NCBI]
|
2.33651e-07
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.76195e-07
|
|
|
CRH
|
[NCBI]
|
6.42883e-09
|
|